| scholarly article | Q13442814 |
| P50 | author | Jan Potempa | Q11718746 |
| P2093 | author name string | Z Chen | |
| J Travis | |||
| T E Hugli | |||
| R G DiScipio | |||
| J A Wingrove | |||
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Porphyromonas gingivalis | Q3214147 |
| P304 | page(s) | 18902-18907 | |
| P577 | publication date | 1992-09-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (Bacteroides) gingivalis | |
| P478 | volume | 267 |
| Q40997028 | A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems |
| Q35785422 | A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system |
| Q32036004 | A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. |
| Q34238754 | Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia |
| Q33634983 | Activities of the Porphyromonas gingivalis PrtP proteinase determined by construction of prtP-deficient mutants and expression of the gene in Bacteroides species. |
| Q35874645 | Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis |
| Q54587595 | Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue. |
| Q34159600 | Attenuation of the virulence of Porphyromonas gingivalis by using a specific synthetic Kgp protease inhibitor |
| Q36337612 | Behavior of two Tannerella forsythia strains and their cell surface mutants in multispecies oral biofilms |
| Q41787988 | Biochemical characterization of the arginine-specific proteases of Porphyromonas gingivalis W50 suggests a common precursor |
| Q37586359 | Breaking bad: manipulation of the host response by Porphyromonas gingivalis. |
| Q34886897 | Cardiovascular disease and the role of oral bacteria |
| Q33606121 | Changes in complement and immunoglobulin G receptor expression on neutrophils associated with Porphyromonas gingivalis-induced inhibition of phagocytosis |
| Q38355964 | Characterization of an adherence and antigenic determinant of the ArgI protease of Porphyromonas gingivalis which is present on multiple gene products. |
| Q33602959 | Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalis. |
| Q34540196 | Cloning and characterization of a new protease gene (prtH) from Porphyromonas gingivalis |
| Q61449507 | Complement Activation as a Helping Hand for Inflammophilic Pathogens and Cancer |
| Q26797414 | Complement Involvement in Periodontitis: Molecular Mechanisms and Rational Therapeutic Approaches |
| Q26862615 | Complement and dysbiosis in periodontal disease |
| Q37769810 | Complement and periodontitis. |
| Q36460034 | Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention |
| Q36302901 | Complement-targeted therapeutics in periodontitis |
| Q37486358 | Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host |
| Q39824311 | Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins. |
| Q37092278 | Cysteine proteinases of microorganisms and viruses. |
| Q39656552 | Discrete proteolysis of focal contact and adherens junction components in Porphyromonas gingivalis-infected oral keratinocytes: a strategy for cell adhesion and migration disabling. |
| Q39510560 | Effect of temperature on growth, hemagglutination, and protease activity of Porphyromonas gingivalis |
| Q33220254 | Expression of Arg-Gingipain RgpB is required for correct glycosylation and stability of monomeric Arg-gingipain RgpA from Porphyromonas gingivalis W50. |
| Q34531163 | Feasibility of an HA2 domain-based periodontitis vaccine. |
| Q35747767 | Generation of C5a by phagocytic cells |
| Q30582298 | Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis |
| Q38716217 | Gingipain of Porphyromonas gingivalis manipulates M1 macrophage polarization through C5a pathway |
| Q37516016 | Hijacking Complement Regulatory Proteins for Bacterial Immune Evasion. |
| Q26827741 | Historical and contemporary hypotheses on the development of oral diseases: are we there yet? |
| Q42262314 | Host-bacteria crosstalk at the dentogingival junction |
| Q37704954 | Human neutrophils and oral microbiota: a constant tug-of-war between a harmonious and a discordant coexistence |
| Q37579925 | Induction of complement C3a receptor responses by kallikrein-related peptidase 14. |
| Q38169798 | Inflammatory and immune pathways in the pathogenesis of periodontal disease |
| Q36022738 | Interactions between coagulation and complement--their role in inflammation |
| Q37097298 | Interpain A, a cysteine proteinase from Prevotella intermedia, inhibits complement by degrading complement factor C3. |
| Q92358830 | Is there a link between genetic defects in the complement cascade and Porphyromonas gingivalis in Alzheimer's disease? |
| Q37332549 | Kinin danger signals proteolytically released by gingipain induce Fimbriae-specific IFN-gamma- and IL-17-producing T cells in mice infected intramucosally with Porphyromonas gingivalis. |
| Q33715219 | Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis |
| Q39570717 | Maturation of the arginine-specific proteases of Porphyromonas gingivalis W50 is dependent on a functional prR2 protease gene |
| Q38481466 | Mechanisms of resistance of Porphyromonas gingivalis to killing by serum complement |
| Q42911622 | Microbial hijacking of complement-toll-like receptor crosstalk |
| Q34001160 | Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis |
| Q35963446 | Oral inflammatory diseases and systemic inflammation: role of the macrophage. |
| Q38365016 | P. gingivalis in Periodontal Disease and Atherosclerosis - Scenes of Action for Antimicrobial Peptides and Complement |
| Q34235972 | Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway |
| Q35544574 | Pathogenic microbes and community service through manipulation of innate immunity |
| Q38946971 | Peptidyl arginine deiminase from Porphyromonas gingivalis abolishes anaphylatoxin C5a activity |
| Q33992343 | Porphyrin-mediated binding to hemoglobin by the HA2 domain of cysteine proteinases (gingipains) and hemagglutinins from the periodontal pathogen Porphyromonas gingivalis |
| Q41001928 | Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function |
| Q36147919 | Porphyromonas gingivalis virulence factors involved in subversion of leukocytes and microbial dysbiosis |
| Q24655246 | Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? |
| Q39655172 | Proteolysis of CD14 on human gingival fibroblasts by arginine-specific cysteine proteinases from Porphyromonas gingivalis leading to down-regulation of lipopolysaccharide-induced interleukin-8 production |
| Q35495294 | Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis |
| Q33876323 | Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase |
| Q80654705 | Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease |
| Q33597234 | RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model |
| Q34727808 | Role of complement in host-microbe homeostasis of the periodontium |
| Q24548705 | Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease |
| Q34045118 | Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. |
| Q37113561 | Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3 |
| Q34786821 | TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. |
| Q37100710 | TLRs and innate immunity |
| Q24618908 | The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss |
| Q35626963 | The Tla protein of Porphyromonas gingivalis W50: a homolog of the RI protease precursor (PrpRI) is an outer membrane receptor required for growth on low levels of hemin |
| Q34514076 | The inflammophilic character of the periodontitis-associated microbiota |
| Q58613479 | The involvement of C5a in the progression of experimental arthritis with Porphyromonas gingivalis infection in SKG mice |
| Q34983578 | The role of the anaphylatoxins in health and disease |
| Q34399545 | Transcriptional profiling of bone marrow stromal cells in response to Porphyromonas gingivalis secreted products |
| Q34001332 | Variable carbohydrate modifications to the catalytic chains of the RgpA and RgpB proteases of Porphyromonas gingivalis W50. |
| Q64070093 | and digestive system cancers |
Search more.